Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods of reducing blood lactate concentration

A technology of lactate and concentration, which is applied in the direction of pharmaceutical formula, dispersion liquid delivery, medical preparations containing active ingredients, etc., to achieve the effect of reducing accumulation

Inactive Publication Date: 2013-05-08
STOKLEY VAN CAMP INC
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, none of these studies suggested a method of lowering blood lactate by administering quercetin to an individual, a method of improving muscle cell performance in an individual by reducing blood lactate concentration, or increasing lactate threshold or A method for maximal lactate steady state to allow prolonged periods of high intensity physical activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of reducing blood lactate concentration
  • Methods of reducing blood lactate concentration
  • Methods of reducing blood lactate concentration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0082] Myocyte Assay for Identifying Compounds that Reduce Lactate Concentrations

[0083] Mouse C2C12 myoblasts were purchased from the American Type Culture Collection (ATCC; Manassas, VA) and grown to 90% in high glucose Dubecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS). Fusion. Myoblasts from purchased batches were grown in T75 flasks and subcultured >5 times, then plated on collagen-coated six-well plates for experiments. To induce myotube differentiation, the FBS-containing matrix was replaced with a matrix containing 2% horse serum or a serum-free matrix and cultured for 5-7 days. Myocytes were cultured and incubated at 37°C, 5% CO with or without antibiotics 2 Maintain myotubes in an incubator.

[0084] Electrical pulses were applied to the myotubes using the C-Pace EP Cell Culture Stimulator (IonOptix; Milton, MA). Cells were stimulated to produce visible and repeatable contractions at a pulse frequency of 0.5 Hz and a pulse duration o...

Embodiment 2

[0086] Myocyte assay with quercetin

[0087] For incubation experiments, pre-treat differentiated myotubes with quercetin and / or other compounds. Approximately 18 hours before electrical pulse stimulation and immediately prior to electrical pulse stimulation, DMEM or serum-free medium containing 2% horse serum was replaced with the same medium containing various concentrations of quercetin or other test compounds. The samples from resting and contraction (incubated with and without compound) were analyzed using the modified method of Lowry and Passonneau (A Flexible System of Enzymatic Analysis, pages 194-199, Academic Press, INC. 1972, which is incorporated herein by reference in its entirety). Cell matrix samples were subjected to enzymatic assays to test for lactate.

Embodiment 3

[0089] Screening of Candidate Compounds for Reducing Lactate Concentrations

[0090] Candidate compounds are screened for their ability to reduce the concentration of lactate in the stroma from contractile cells relative to cells supplemented with quercetin and / or relative to cells exposed to one or more other candidate compounds. Differentiated myotubes are pretreated with the candidate compound, preferably in water-soluble form. The DMEM or serum-free medium containing 2% horse serum is replaced with the same medium containing the candidate compound at a concentration of about 0.001 mM to about 10 mM about 18 hours before and immediately before electrical pulse stimulation.

[0091] Differentiated myotubes are stimulated with electrical pulses to produce visible repetitive contractions of the cells. A pulse frequency of 0.5 Hz and a duration of 24 ms for 90 minutes was used. The lactate concentration in the cell culture medium is determined and compared to a control experi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is directed to methods for reducing blood lactate concentration during exercise, physical activity or athletic performance.

Description

[0001] relevant application data [0002] This application claims priority to U.S. Provisional Patent Application No. 61 / 383,973, filed September 17, 2010, and U.S. Provisional Patent Application No. 61 / 498,007, filed June 17, 2011, each of which is set forth in its entirety Incorporated herein by reference for all purposes. field of invention [0003] The present invention relates to the field of improving athletic performance by reducing blood lactate concentration and / or increasing lactate threshold (ie, maximum lactate steady state in individuals engaging in high intensity athletic activity). The invention further relates to the field of assays, in particular to the field of assays for determining the ability of compounds to reduce blood lactate concentrations during high-intensity exercise. Background of the invention [0004] During exercise, lactic acid, or lactate, is produced in contracting skeletal muscles. Unless lactate is utilized by cells, it is cleared from ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A23L1/30A23L2/38A23L2/52A61K31/352
CPCA23L1/3002A23L2/38A61K31/352A23L2/52A23L33/105G01N33/48728A61P21/00A61P3/00A61P3/02G01N33/5061A23V2002/00A61K9/0095
Inventor J·J·扎西维尔亚M·A·泊尔纳J·W·史密斯
Owner STOKLEY VAN CAMP INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com